RPL22L1 and glioblastoma: Compositional heterogeneity also emerges at the level of RNA processing, as alternative splicing of ribosomal protein paralogs—including RPL22 and RPL22L1—differs across tumour states and cellular phenotypes (Larionova et al., 2022), suggesting that ribosomal diversity in GBM may arise through multiple regulatory layers.